Mediterranean Towers Ventures

Mediterranean Towers Ventures is an AgeTech-focused corporate venture capital firm backed by Mediterranean Towers (TASE: MDTR), Israel's market-leading retirement living developer and operator. Founded in 2017 and based in Ganei Tikva, Israel, it is the first Israeli investment fund focused exclusively on technological innovations for older adults. The fund opened trading on the Tel Aviv Stock Exchange in a ceremony led by TASE CEO Mr. Ben-Zeev and Mediterranean Towers Chairman Yair Seroussi. Managing Director Omer Brakin, who also serves as VP of Business Development at Mediterranean Towers, leads a team of approximately 12 with backgrounds spanning venture investment, capital markets, real estate, and healthcare. The fund invests at pre-seed and seed stages in Israeli AgeTech startups tackling loneliness, improving medical outcomes, and enhancing quality of life for older adults. Check sizes range from $100,000 to $500,000. The portfolio of six companies includes Maolac (AI-powered bio-functional proteins derived from milk, invested July 2022), Travaxy (accessible travel platform), XRHealth (a VR and AR therapeutic healthcare platform that acquired RealizedCare in February 2025 and NeuroReality in November 2024), Uniper (eldercare fitness), and APA. The fund's primary competitive advantage is direct market access through Mediterranean Towers' retirement communities, providing portfolio companies with four decades of institutional relationships with older adults and real-world testing environments that pure financial investors cannot replicate. Portfolio companies gain structured access to genuine end users, clinical feedback loops, and commercial pathways within the Israeli eldercare ecosystem.